Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02363010 · ClinicalTrials.gov registry record · NA
Project Impact: An Innovative Approach to Weight Loss Maintenance
A NA study, sponsored by Drexel University.
- Completed
- Registry status
- NA
- Development phase
- 320
- Enrollment target
NCT02363010: Completed NA study, sponsored by Drexel University.
NCT02363010 is a NA study that has completed, run by Drexel University. The registered enrollment target is 320 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02363010, a NA study, has completed, sponsored by Drexel University.
- COMPLETED
- Registry status
- NA
- Development phase
- 320 participants
- Enrollment target
Study Summary
The major goal of this project is to evaluate an innovative approach to obesity. This study will determine if behavioral treatment can be improved by 1) implementing a primary focus on PA following initial weight loss treatment, and 2) using a novel, acceptance-based approach to the promotion of PA.
Primary Outcome
Objectively measured in the research clinic at each time point on a scale
Interventions
- BEHAVIORAL Gold Standard Behavior Therapy for Weight Loss
- BEHAVIORAL Behavior Therapy for Weight Loss with Physical Activity Emphasis
- BEHAVIORAL Acceptance-based Behavior Therapy for Weight Loss with PA emphasis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2014-08-01 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
What the finished NCT02363010 record still lists
NCT02363010 is an interventional study that assigns participants to a tested intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 3 interventions - of which Gold Standard Behavior Therapy for Weight Loss is the first listed.
NCT02363010 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02363010 about?
NCT02363010 is a clinical study titled "Project Impact: An Innovative Approach to Weight Loss Maintenance". The major goal of this project is to evaluate an innovative approach to obesity. This study will determine if behavioral treatment can be improved by 1) implementing a primary focus on PA following initial weight loss treatment, and 2) using a novel, acceptance-based approach to the promotion of PA.
What is the current status of trial NCT02363010?
This trial is currently completed. It is a NA study. The enrollment target is 320 participants. The study started on 2014-08-01. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT02363010?
The interventions under investigation include: Gold Standard Behavior Therapy for Weight Loss (BEHAVIORAL), Behavior Therapy for Weight Loss with Physical Activity Emphasis (BEHAVIORAL), Acceptance-based Behavior Therapy for Weight Loss with PA emphasis (BEHAVIORAL).
Who is sponsoring clinical trial NCT02363010?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02363010's enrollment target sits among peer trials
320 315th of 2000 higher than 1,680 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02763683 · 320 participants
Investigations of Dementia in Parkinson Disease
- NCT03331198 · 320 participants · Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- NCT03458832 · 320 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
- NCT03551951 · 320 participants
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI